Table 2

- The laboratory variables before and after treatment.

CharacteristicsFBG (mmol/L)HbA1c (%)CRP (mg/dl)WBC (×109)Alb (g/L)ABI
Control Group (n=50)
D011.2±1.510.9±1.240.8±9.214.0±1.628.9±3.80.7±0.1
D611.0±1.410.9±1.228.8±7.012.9±1.231.1±3.60.7±0.1
NPWT Group (n=50)
D010.7±1.710.8±1.041.6±9.613.2±3.329.6±4.20.7±0.1
D610.6±1.810.5±0.924.1±9.39.5±2.034.4±4.20.7±0.1
mean difference0.05-0.26-5.35-3.062.760.01
(95%CI)(-0.32 to 0.43)(-0.47 to -0.06)(-7.44 to -3.26)(-3.51 to -2.60)(1.74 to 3.79)(-0.02 to 0.03)
p value0.7730.0132.0×10-61.1×10-235.8×10-70.923
  • FBG: fasting blood glucose, HbA1c: glycosylated hemoglobin, CRP: C reactive protein, WBC: white blood cells, Alb: albumin, ABI: Ankle/Brachial Index, NPWT: negative pressure wound therapy, Mean difference: difference (intervention-control) is shown for mean changes from baseline (D6-D0). Analysis of covariance analysis was used to compare the difference of change from baseline between the 2 groups with the baseline value as a covariate, p<0.0083 was deemed significant.